PuertoRicoCommunityActionResearch and Engagement (PR-CARE) to EliminateDisparities in Diagnostic of COVID-19amongRuralUnderserved and VulnerablePopulations.
Project Number1U01MD017426-01
Former Number1U01MH129913-01
Contact PI/Project LeaderSANCHEZ, MARIZAIDA Other PIs
Awardee OrganizationUNIVERSITY OF PUERTO RICO MED SCIENCES
Description
Abstract Text
In PuertoRico, the COVID-19 burden in the elderly population is significant as 23% of the confirmed COVID-19 cases and
75% of the deaths have been reported in this group with a low testing rate (3.4 per 100,000) in those > 65 years. The
knowledge, beliefs, attitudes, and practices about the risk of infection from COVID-19, symptoms, testing and
vaccination, remain a public health concern in PuertoRico. In 2019, 21.3% of the population living in PR were elderly (>
65 years) with 43.3% living in poverty, were isolated, and medically vulnerable due to their chronic diseases. Isolation for
elders has been exacerbated due to the high rate of migration of their family members that culturally cared and lookout
for them. The PuertoRicoCommunityActionResearch and Engagement (PR-CARE) initiative aims to focus on the
elderly communities in PR who are disadvantaged by geography, sexual and/or gender identification, homelessness
and/or income to identify how multiple factors serve to disadvantage this at-risk population in COVID-19 testing and
vaccine uptake. Our well-established community partner network, using a mixed methods research strategy, has the
goal of examining how social determinants of health, in addition to critical policy and environmental factors, address
testing and vaccine access and uptake in elderly (> 65 years old) populations in PuertoRico who suffer from high levels
of social vulnerability (i.e., homeless), who are geographically isolated (i.e., living in isolated or rural areas), living in
poverty, and gender or sexual diverse (i.e., L.G.B.T.T.Q.I.A.+). Our strategies are guided by four theoretical frameworks:
CommunityEngagement Continuum, Intersectionality-Informed Approach, Anderson’s Behavioral Model of Health, and
Historical Trauma. These models will enable us to portray a critical array of multi-domain determinants of health to
understand health disparities and healthcare utilization, specifically COVID-19 testing, and vaccinations, in vulnerable
elderly communities. Our aims are to: 1) assess federal and PuertoRico Commonwealth policy implications on COVID-19
testing in low-resourced and socially vulnerable elderly in PuertoRico; 2) examine individual and social determinants of
health that influence the uptake of the COVID-19diagnostics among low-resourced and socially vulnerable elderly in
PuertoRico and 3) combine results from the systematic policy review and key informants (Aim 1: qualitative) and elderly
individuals (Aim 2: quantitative and qualitative) to identify challenges, barriers and effective strategies and language to
support and improve COVID-19 testing and other related health outcomes in this vulnerable population. The communityengagementresearch that comprises PR-CARE will work to expand the scope, reach, access to and uptake of COVID-19
testing for vulnerable elderly populations in PuertoRico. Concurrently, it will identify and create permanent pathways in
health policy that increase the availability of health services for vulnerablepopulations, promoting health equity using
the lens of social, ethical, and behavioral implications.
Public Health Relevance Statement
PR-CARE, focusing on elderly (> 65) communities in PuertoRico who are disadvantaged by geography,
sexual/gender identification, homelessness and/or income are highly vulnerable to COVID-19. This study uses
a mixed methods approach to identify factors that shape this Caribbean Hispanic population’s health and
wellness is impacted by social, ethical, behavioral, structural, historical, and policy issues. Conducted through a
community-academic engagement framework, the explanatory sequential mixed-method approach of surveys,
policy review and interviews will be used to improve our understanding of factors that shape decisions related to
health behaviors, especially those related to COVID-19 testing and vaccination uptake.
NIH Spending Category
No NIH Spending Category available.
Project Terms
ActionResearchAddressAdoptedAttitudeBehavioralBehavioral ModelBeliefCOVID-19COVID-19diagnosticCOVID-19 disparityCOVID-19 impactCOVID-19 testingCOVID-19 vaccinationCOVID-19 vaccineCaribbean HispanicCaringCessation of lifeChronic DiseaseClinical ResearchCollaborationsCommunitiesCommunityActionsComputer AssistedDataDisadvantagedDiscriminationElderlyEnvironmental Risk FactorEthicsFamily memberFundingFutureGenderGenerationsGeographyGoalsGovernmentHealthHealth PolicyHealth Services AccessibilityHealth behaviorHispanicHomelessnessIncomeIndividualInterventionInterviewKnowledgeLanguageLow incomeMethodsModelingNational Institute of General Medical SciencesOutcomePathway interactionsPerceptionPhasePoliciesPopulationPopulations at RiskPovertyPublic HealthPuerto RicanPuertoRicoRADx UnderservedPopulationsReduce health disparitiesReportingResearchResearch MethodologyResourcesRuralSARS-CoV-2 infectionServicesSexual and Gender MinoritiesShapesSocial WorkStructureSurveysSymptomsTestingThickTranslational ResearchTraumaUnderserved PopulationVaccinationValidationVulnerablePopulationsWorkbasecommunity engaged researchcommunityengagementcommunity partnershipcoronavirus diseasedisparity eliminationdisparity reductiongender diversitygeographic barrierhealth care service utilizationhealth disparityhealth equity promotionhuman old age (65+)improvedinfection riskinformantintersectionalitylensmedical vulnerabilitymigrationpolicy implicationpopulation healthprogramsrural arearuralunderservedsocialsocial health determinantssocial vulnerabilitytesting accessuptakevaccine acceptancevaccine accessvulnerablecommunity
National Institute on Minority Health and Health Disparities
CFDA Code
310
DUNS Number
948108063
UEI
KWTAB1GYM4L9
Project Start Date
01-January-2022
Project End Date
30-November-2023
Budget Start Date
01-January-2022
Budget End Date
30-November-2022
Project Funding Information for 2022
Total Funding
$1,070,547
Direct Costs
$750,000
Indirect Costs
$320,547
Year
Funding IC
FY Total Cost by IC
2022
NIH Office of the Director
$1,070,547
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U01MD017426-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U01MD017426-01
Patents
No Patents information available for 1U01MD017426-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U01MD017426-01
Clinical Studies
No Clinical Studies information available for 1U01MD017426-01
News and More
Related News Releases
No news release information available for 1U01MD017426-01
History
No Historical information available for 1U01MD017426-01
Similar Projects
No Similar Projects information available for 1U01MD017426-01